Fabrizio Gasparini

发表

Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [11C]-ABP688 PET imaging in healthy volunteers

Simon M. Ametamey, Valerie Treyer, Alfred Buck, 2021, NeuroImage.

Evaluation of the Metabotropic Glutamate Receptor Subtype 5 Using PET and 11C-ABP688: Assessment of Methods

Valerie Treyer, Alfred Buck, Johannes Streffer, 2007, Journal of Nuclear Medicine.

Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice

Ilse Gantois, Ben A. Oostra, Rob Willemsen, 2013, Behavioural Brain Research.

Identification of heavy, energetic, hadronically decaying particles using machine-learning techniques

Yi Wang, Andrea Benaglia, Yi Zhang, 2020, Journal of Instrumentation.

Radiolabelling and in vivo evaluation of 11C–MPEP as a pet radioligand for the imaging of the metabotropic glutamate receptor 5 (MGLUR5)

Simon M. Ametamey, M. Kokic, Pius August Schubiger, 2001 .

Performance of the CMS Level-1 trigger in proton-proton collisions at √s = 13 TeV

Yi Wang, Andrea Benaglia, Ian Watson, 2020 .

[3H]‐M‐MPEP, a Potent, Subtype‐Selective Radioligand for the Metabotropic Glutamate Receptor Subtype 5.

Fabrizio Gasparini, F. Gasparini, 2002 .

Search for resonant tt production in proton-proton collisions at √s = 8 TeV

Andrea Benaglia, Yu-Wei Chang, Marco Rossini, 2015, 1506.03062.

mGluR5 antagonists: discovery, characterization and drug development.

Baltazar Gomez-Mancilla, Fabrizio Gasparini, W. Spooren, 2008, Current opinion in drug discovery & development.

Search for a Higgs boson decaying into a b-quark pair and produced in association with b quarks in proton–proton collisions at 7 TeV

Andrea Benaglia, Yu-Wei Chang, Marco Rossini, 2013 .

Studies of dijet pseudorapidity distributions and transverse momentum balance in pPb collisions at sNN=5.02TeV

Andrea Benaglia, Yu-Wei Chang, Marco Rossini, 2014 .

Search for a massive resonance decaying to a pair of Higgs bosons in the four b quark ﬁnal state in proton–proton collisions at √ s = 13 TeV

Andrea Benaglia, Francesco Fienga, Stavros Mallios, 2018 .

Search for a $W^\prime$ or Techni-$\rho$ Decaying into $WZ$ in $pp$ Collisions at $\sqrt{s}=7$ TeV

Andrea Benaglia, Yu-Wei Chang, Marco Rossini, 2012 .

Search for new physics in final states with an energetic jet or a hadronically decaying W or Z boson and transverse momentum imbalance at √s=13 TeV

Yi Wang, Andrea Benaglia, Francesco Fienga, 2018 .

The ZEUS barrel and rear muon detector

Roberto Carlin, L. Stanco, Stefano Maria Mari, 1993 .

Search for gluino mediated bottom- and top-squark production in multijet final states in pp collisions at 8 TeV

Andrea Benaglia, Steven R. Simon, A. Tsirou, 2013, 1305.2390.

Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056

Janice Branson, Jacques S. Beckmann, Nouchine Hadjikhani, 2011, Science Translational Medicine.

Performance of the CMS muon detector and muon reconstruction with proton-proton collisions at √s=13 TeV

Yi Wang, Andrea Benaglia, Francesco Fienga, 2018, Journal of Instrumentation.

[(3)H]-M-MPEP, a potent, subtype-selective radioligand for the metabotropic glutamate receptor subtype 5.

Fabrizio Gasparini, K. Lingenhöhl, F. Gasparini, 2002, Bioorganic & medicinal chemistry letters.

Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant

Aaron Isaacs, Ben A. Oostra, Rob Willemsen, 2012, Psychopharmacology.

Measurement of the differential cross section for isolated prompt photon production in pp collisions at 7 TeV

Andrea Benaglia, Steven R. Simon, A. Tsirou, 2011 .

Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.

Yves P Auberson, Alfred Buck, Michael Honer, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

mGlu5 receptor antagonists: a novel class of anxiolytics?

Fabrizio Gasparini, W. Spooren, F. Gasparini, 2004, Drug news & perspectives.

Search for high mass dijet resonances with a new background prediction method in proton-proton collisions at $\sqrt{s}=$ 13 TeV

Yi Wang, Andrea Benaglia, Ian Watson, 2020 .

Alignment of the CMS tracker with LHC and cosmic ray data

Andrea Benaglia, Yu-Wei Chang, Marco Rossini, 2014 .

Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome

Mark F. Bear, Eva Loth, Jacqueline N. Crawley, 2017, Nature Reviews Drug Discovery.

Treatment of Levodopa-Induced Dyskinesias : Results of 2 Randomized Controlled Trials

Daniela Berg, Maria Stamelou, Marc Vandemeulebroecke, 2011 .

Metabotropic glutamate receptor mGluR5 is not involved in the early hemodynamic response

Alfred Buck, Bruno Weber, Renaud Jolivet, 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Search for physics beyond the standard model in final states with a lepton and missing transverse energy in proton-proton collisions at √s=8 TeV

Andrea Benaglia, Yu-Wei Chang, Marco Rossini, 2015 .

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

Roland Heckendorn, Hans Allgeier, Fabrizio Gasparini, 1999, Neuropharmacology.

Performance of reconstruction and identification of τ leptons decaying to hadrons and vτ in pp collisions at √s=13 TeV

Yi Wang, Andrea Benaglia, Francesco Fienga, 2018, Journal of Instrumentation.

A deep neural network to search for new long-lived particles decaying to jets

Yi Wang, Andrea Benaglia, Ian Watson, 2019 .

ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: identification, in vitro pharmacology, pharmacokinetic and biodistribution studies.

Steven Whitebread, Yves P Auberson, Daniel Hoyer, 2007, Bioorganic & medicinal chemistry.

Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives.

Fabrizio Gasparini, F. Gasparini, J. Pin, 2002, Current opinion in pharmacology.